Stomach Cancer Trial, Recruiting (NCT07401173)

Stomach Cancer Trial, Recruiting NCT07401173 Sponsor: Qun Zhao Condition: Stomach Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT07401173 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Stomach Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Adults aged 18 or older
People who have been diagnosed with a specific type of stomach cancer (gastric adenocarcinoma) confirmed through a tissue test
People who are scheduled for planned stomach cancer removal surgery intended to fully remove the cancer (open, keyhole, or robotic surgery)
People who have had a standard abdominal CT scan with contrast dye (a type of detailed X-ray) taken within 14 days before their surgery
People who are willing to sign a consent form agreeing to take part

Who may not be able to join:

People who need emergency surgery due to a stomach perforation, blockage, or severe bleeding
People where, during surgery, the cancer is found to have spread to distant parts of the body or cannot be fully removed
People who have had another type of cancer in the last 5 years (not including the current stomach cancer)
People who are pregnant or breastfeeding
People whose CT scan images have significant interference from metal (such as implants) that makes the images difficult to analyse

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 27 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Qun Zhao, th

Phone: +8631186095363

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07401173

Sponsor: Qun Zhao

Phase: Not Applicable

Status: Recruiting

Condition: Stomach Cancer

Trial contact: +8631186095363

More information: https://clinicaltrials.gov/study/NCT07401173

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Adults aged 18 or older
People who have been diagnosed with a specific type of stomach cancer (gastric adenocarcinoma) confirmed through a tissue test
People who are scheduled for planned stomach cancer removal surgery intended to fully remove the cancer (open, keyhole, or robotic surgery)
People who have had a standard abdominal CT scan with contrast dye (a type of detailed X-ray) taken within 14 days before their surgery
People who are willing to sign a consent form agreeing to take part

Who may not be able to join:

People who need emergency surgery due to a stomach perforation, blockage, or severe bleeding
People where, during surgery, the cancer is found to have spread to distant parts of the body or cannot be fully removed
People who have had another type of cancer in the last 5 years (not including the current stomach cancer)
People who are pregnant or breastfeeding
People whose CT scan images have significant interference from metal (such as implants) that makes the images difficult to analyse

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 27 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Qun Zhao

Registry

ClinicalTrials.gov

Start date

1 March 2026

Est. completion

1 May 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Incidence of Major Postoperative Complications (Clavien-Dindo Grade ≥ II); Human-AI Collaborative Diagnostic Performance in Gastric Cancer Surgery: Accuracy and Observer Agreement

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov